April 13th, 2026 - Stanford Report News
A new technique from Stanford Bio-X affiliated faculty members Guosong Hong, Jun Ding, Xiaoke Chen, and Michael Lin, with co-authors Stanford Bio-X Bowes Fellow Marigold Malinao and Stanford Bio-X Fellow Nicholas Rommelfanger and lead author Dr. Shan Jiang - using ultrasound waves to activate light-emitting nanoparticles - could be used to manipulate cell signals or facilitate light-based medical treatments in the future. The work was partially supported by a 2022 Stanford Bio-X Interdisciplinary Initiatives Program Seed Grant titled: Label-free and transgene-free detection of neurotransmitters in the enteric nervous system with ultraflexible intraplexus electronics and a 2020 Stanford Bio-X Interdisciplinary Initiatives Program Seed Grant titled: Ultrasound-controlled in vivo gene editing via photoswitchable CRISPR-Cas9.

December 8, 2025
Andreas Tolias, a Professor in the Stanford Department of Ophthalmology at the Byers Eye Institute, as well as a Stanford Bio-X affiliated faculty member and Clark Center resident faculty member, is a senior author on the publication in Nature Electronics. Fabricated as a single chip, the new implant is orders of magnitude faster and smaller than today’s state-of-the-art brain-computer interfaces, offering an opportunity for more efficacious treatment of a number of neurological conditions.